Conference Grant (R-13) Covering Three Years of Cochlear Implant Clinical Research Symposia to be held in 2021, 2022 and 2023

项目总结/摘要 该申请寻求部分资金用于三年的人工耳蜗（CI）临床研究 2021年4月（达拉斯），2022年5月，美国髋关节植入物联盟召开的会议 （华盛顿，DC）和2023年春季西海岸待定。CI会议提供了一个独特的机会， 来自整个护理连续体的CI临床医生（即，耳鼻喉科医生听力学家语言病理学家 心理学家），教育家和科学家一起学习。将提供虚拟参与。 在补助金的第一年，我们将召开CI 2021 Cocoear Implantation：It Takes a Village。的 CI 2021计划将侧重于与人工耳蜗植入体特定方面相关的临床研究 儿童和成人的过程，包括：管理CI患者范围的团队方法，包括 双语患者和家庭，特殊需要人群和其他接受人工耳蜗植入的人 扩大适应症;儿科和成人患者的治疗、教育和家庭参与的作用; 听力保护;远程医疗;认知和对结果的影响;前庭评估;进展 CI和手术技术;以及管理听力损失的替代方法。越来越需要 一个团队，其中包括个人谁不是“传统”的CI临床医生是公认的光， 扩大的迹象正在推动现在被认为是良好的CI候选人的个人的增长。 学生可以申请豁免注册和财政支持，并可以进入学生海报 由跨学科委员会进行面试的竞争。会后的一个下午 为聋人和重听成年人、听力损失儿童的父母和其他家庭举办的研讨会 成员将举行分享翻译研究的内容，为非临床观众。 我们将探索最佳实践模式，以支持CI适应症的扩展， 有资格接受治疗的患者数量增加。会议的三个具体目标是：（1） 探索在扩展适应症下植入的CI受体的比较结局，包括特殊适应症 需求人群、双语患者和影响性能的器械变量;（2）评价 临床实践模型，以确定它们是否能够有效地支持不断增长的患者群体 并建议临床实践的未来变化;（3）确定需要更好地建议患者的研究 并解决CI接受人群中结果的当前变异性。

Project Summary/Abstract This application seeks partial funding for three years of cochlear implant (CI) clinical research conferences to be convened by the American Cochlear Implant Alliance in April 2021 (Dallas), May 2022 (Washington, DC) and Spring 2023 West Coast TBD. The CI meetings provide a unique opportunity for CI clinicians from across the continuum of care (i.e., ENTs, audiologists, speech pathologists, psychologists), educators, and scientists to learn together. Virtual participation will be offered. In the first year of the grant, we will convene CI2021 Cochlear Implantation: It Takes a Village. The program for CI2021 will focus on clinical research relative to specific aspects of the cochlear implant process for children and adults including: team approach to managing the range of CI patients including bilingual patients and families, special needs populations and others receiving cochlear implants under expanded indications; role of therapy, education and family engagement for pediatric and adult patients; hearing preservation; telehealth; cognition and effect on outcomes; vestibular assessment; advances in CI and surgical techniques; and alternative methods of managing hearing loss. Increasingly the need for a team that includes individuals who are not “traditional” CI clinicians is recognized in light of the expanded indications that are driving growth in individuals now considered good CI candidates. Students may apply for waived registration and financial support and may enter a student poster competition with interviews conducted by an interdisciplinary committee. A post-conference afternoon seminar for deaf and hard of hearing adults, parents of children with hearing loss, and other family members will be held to share translational research content for a non-clinician audience. We will explore the best practice models to support an expansion in CI indications and the likely increased volume of patients eligible for care. Our three specific aims for the conference are to: (1) explore comparative outcomes of CI recipients implanted under expanded indications including special needs populations, bilingual patients, and device variables that contribute to performance; (2) evaluate clinical practice models to determine if they are able to effectively support a growing patient population and suggest future changes in clinical practice; (3) determine research needed to better advise patients and address current variability in outcomes among the CI recipient population.